Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses in the Northeast United States
Status:
Withdrawn
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
In this study, daylight PDT will be administered to interested patients at
Dana-Farber/Brigham and Women's Cancer Center. Daylight PDT has been shown to be an effective
and painless alternative to traditional PDT. Daylight PDT involves application of the
photosensitizer in the physician's office followed by exposure to daylight.